cprx stock price target
Catalyst Pharmaceuticals stock price target raised to 10 from 9 at Oppenheimer Mar. 2 days agoShares of CPRX opened at 1398 on Monday.
One Reason Why Catalyst Pharmaceuticals Cprx Stock Is Jumping Today Thestreet
The forecasts range from a.
. Stock Price Forecast. The average price target is. Price target in 14 days.
Get a real-time Catalyst. CPRX Stock Price Prediction 1670 1912 Upside Based on 5 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. ET by Tomi Kilgore Catalyst Pharmaceuticals started at outperform.
Lowering target price to 1500 CATALYST PHARMACEUTICALS INC has an Investment Rating of BUY. The latest price target for Catalyst Pharmaceuticals NASDAQ. An Industry Subrating of High.
The 2 year net income to common stockholders growth rate now stands at 492. This is 505 more than the trading day before Thursday 20th Oct 2022. The best long-term short-term Catalyst Pharmaceuticals.
The average CPRX stock price target of 1670 per share implies 34 upside over the next twelve months. Close price at the end of the last trading day Friday 21st Oct 2022 of the CPRX stock was 1341. A strong rally in Catalyst Pharmaceuticals stock might have been.
Get a real-time Catalyst Pharmaceuticals Inc. CPRX -226 DJIA -039 SP Mid Cap 400 -008 Health CareLife Sciences 011 Overview Per-Share Earnings Actuals Estimates Catalyst Pharmaceuticals Inc. Over the past 15 months CPRXs average price target has gone up 94.
And even if the CPRXs share succeeded to reach the. CPRX stock forecast and price target Find the latest Catalyst Pharmaceuticals Inc. Its year over year net cashflow from.
20 2019 at 759 am. Based on short-term price targets offered by five analysts the average price target for Catalyst Pharmaceutical comes to 1690. The analyst firm set a price target.
CPRX reports an average of 4491 for its upside potential over the past 41 weeks. Catalyst Pharma stock forecast analyst price target predictions based on 5 analysts offering 12-months price targets for CPRX in the last 3 months. CPRX was reported by Roth Capital on Wednesday August 24 2022.
A target price of 15000000. According to 11 stock analysts the average 12-month stock price forecast for CPRX stock is 1724 which predicts an increase of 2149. Stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.
CPRX stock price quote with breaking news financials statistics charts and more. The stock has a market capitalization of 144 billion a PE ratio of 2741 and a beta of 130. Stocks current price level is -1071 above from estimated low price target while it is -2857 below the estimated high.
The average BMY stock price target of 7933 per share implies. The 4 year cash and equivalents growth rate now stands at 63198. See Catalyst Pharmaceuticals Inc.
CPRX analyst stock forecast price target and recommendation. Catalyst Pharmaceuticals has a 1 year. The average CPRX stock price target of 1670 per share implies 34 upside over the next twelve months.
Current Price 1419 Target Price 1690 191 Upside 4 19 Catalyst Pharmaceuticals Stock Rating What analysts recommend for CPRX stock on a scale from 1. Catalyst Pharmaceuticals Stock Forecast CPRX stock price prediction.
Catalyst Pharmaceuticals Inc Cprx Stock Price Quote News Stock Analysis
Catalyst Pharmaceuticals Inc Nasdaq Cprx Position Reduced By Allspring Global Investments Holdings Llc The Am Reporter
Cprx Stock Price And Chart Nasdaq Cprx Tradingview
Catalyst Pharmaceuticals Inc Research Ratings Cprx Barron S
Biotech Penny Stocks Get A Boost After Aptorum S 1 066 Move
5 Penny Stocks With High Volume On March 30
Cprx Catalyst Pharmaceuticals Inc Stock Quote Cnnmoney Com
Cprx Stock Price And Chart Nasdaq Cprx Tradingview
Cprx Is Its Stock Price A Worthy Investment Learn More
Catalyst Pharmaceuticals Inc Cprx Stock Analysis October 2022 Wallmine
Catalyst Pharmaceuticals Inc Nasdaq Cprx Share Price Rns News Quotes Charts Cprx
Small Cap Catalyst Pharmaceuticals Is Among Market S Best Price Performers Valuewalk
One Reason Why Catalyst Pharmaceuticals Cprx Stock Is Jumping Today Thestreet
Blackrock Inc Ownership In Cprx Catalyst Pharmaceuticals Inc 13f 13d 13g Filings Fintel Io
5 Penny Stocks With High Volume On March 30
Biotech Stocks Notch A Blazing Path In 2022 Why The Good Times Aren T Over Investor S Business Daily
Catalyst Pharmaceuticals Next Big Thing On S P Smallcap 600
Cprx Short Interest Catalyst Pharmaceuticals Inc Stock Short Squeeze Borrow Rates